Scientists say the arthritis drug Bextra may pose increased risk of cardiovascular troubles. Bextra is related to Vioxx, which was pulled off the market in September for the same reason. Now, doctors worry that all related drugs could cause similar problems. Hear NPR's Richard Knox.
Copyright 2004 NPR
This news story is funded in large part by Connecticut Public’s Members — listeners, viewers, and readers like you who value fact-based journalism and trustworthy information.
We hope their support inspires you to donate so that we can continue telling stories that inform, educate, and inspire you and your neighbors. As a community-supported public media service, Connecticut Public has relied on donor support for more than 50 years.
Your donation today will allow us to continue this work on your behalf. Give today at any amount and join the 50,000 members who are building a better—and more civil—Connecticut to live, work, and play.
